TIM
ANIP icon

Tortoise Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Tortoise Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$92 – 306
2025
Q3 		$92 Buy
+1
New +$82 ﹤0.01% 1400

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tortoise Investment Management's ANIP Position: Q4 2025 in Review

Tortoise Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 1 share — an estimated $92 sold.

Tortoise Investment Management first reported a position in ANIP in Q3 2025 and held it in 1 quarter. The position peaked at $92 in Q3 2025. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Tortoise Investment Management reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tortoise Investment Management sold 1 ANI Pharmaceuticals share in Q4 2025, an estimated $92.
  • Tortoise Investment Management first reported a position in ANI Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Tortoise Investment Management's ANI Pharmaceuticals position peaked at $92 in Q3 2025.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Tortoise Investment Management's 13F filing for Q4 2025, filed 6 Feb 2026.